Abstract
The identification of therapeutic agents that can prevent the pancreatic injury after endoscopic retrograde cholangiopancreatography (ERCP) is of considerable importance.
| Original language | English |
|---|---|
| Pages (from-to) | 1-7 |
| Number of pages | 7 |
| Journal | Gastrointestinal Endoscopy |
| Volume | 51 |
| Publication status | Published - 2000 |
Keywords
- Acute Disease
- Amylases
- Cholangiopancreatography, Endoscopic Retrograde
- Gabexate
- Hormones
- Humans
- Octreotide
- Pain
- Pancreas
- Pancreatitis
- Serine Proteinase Inhibitors
- Somatostatin
- Treatment Outcome
Fingerprint
Dive into the research topics of 'Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver